SIRT6 and neoplasm: Specifically, we crossed MMTV-PyMT+/− male mice with Sirt6+/− female animals and compared tumor latency and mouse survival between MMTV-PyMT+/−; Sirt6+/+ and MMTV-PyMT+/−; Sirt6+/− mice.